| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.11.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 03.11.2025 | 1.213 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 03.11.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 03.11.2025.ISIN NameCA74971G4016 RF... ► Artikel lesen | |
| 03.11.25 | XFRA 7PL0: AUSSETZUNG/SUSPENSION | 271 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROSTALUND AB 7PL0... ► Artikel lesen | |
| 24.10.25 | ProstaLund AB: PROSTALUND AB (publ) - Interim report January-September 2025 | 248 | GlobeNewswire (Europe) | Third quarterJuly 1 - September 30Net sales reached MSEK 2.2 (3.5)Operating profit/loss totaled MSEK -2.6 (-4.4)Loss after taxes MSEK -2.6 (-4.5)Earnings per share, before and after dilution amounted... ► Artikel lesen | |
| 15.10.25 | Delisting of ProstaLund AB from Nasdaq First North Growth Market | 370 | GlobeNewswire | ProstaLund AB has applied for its shares to be delisted from Nasdaq First North Growth Market.
Nasdaq Stockholm AB has approved the application and decided to delist the shares of ProstaLund... ► Artikel lesen | |
| 12.09.25 | ProstaLund AB: ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman | 334 | GlobeNewswire (Europe) | ProstaLund has signed a collaboration agreement with the XEN Group, a prominent distributor of advanced innovative products with solid experience and contacts in the UAE and Oman. Through this partnership... ► Artikel lesen | |
| 10.09.25 | ProstaLund AB: ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market | 248 | GlobeNewswire (Europe) | ProstaLund has entered into a collaboration agreement with Mayumana Healthcare, a leading distributor of innovative urological solutions with strong expertise in the Benelux market. The partnership... ► Artikel lesen | |
| 21.08.25 | ProstaLund AB: ProstaLund AB - Interim Report January-June 2025 | 223 | GlobeNewswire (Europe) | April 1 - June 30Net sales reached MSEK 2.1 (2.8)Operating profit/loss totaled MSEK -6.3 (-7.2)Loss after taxes MSEK -6.5 (-7.1)Earnings per share, before and after dilution amounted to SEK -1.80 (-3.72)Cash... ► Artikel lesen | |
| PROSTALUND Aktie jetzt für 0€ handeln | |||||
| 11.07.25 | The observation status for ProstaLund AB is updated | 370 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
Today... ► Artikel lesen | |
| 01.07.25 | The observation status for ProstaLund AB is updated | 323 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,270 | -1,20 % | Dividendenbekanntmachungen (25.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AQUILA SA FR0010340711 - 0,25 EUR ARISTOCRAT LEISURE LIMITED AU000000ALL7 0,5 AUD 0,3071 EUR ARKEMA SA FR0010313833 - 3,6 EUR BLEECKER... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,190 | -0,13 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,920 | +0,11 % | Globeone veröffentlicht Future Readiness Index 2026: Weniger als die Hälfte der deutschen Unternehmen gilt als zukunftsfähig - dm, Deutsches Rotes Kreuz, Rossmann und Siemens Healthineers vorne | Köln (ots) - Die deutsche Wirtschaft steht unter massivem Druck - und mit ihr die Zukunftsfähigkeit vieler Unternehmen. Geopolitische Spannungen, Ressourcenknappheit, technologische Disruptionen sowie... ► Artikel lesen | |
| GENEDX | 51,99 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| QTREX QUANTUM | 3,070 | 0,00 % | Inspira Technologies: QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor | ||
| PRIVIA HEALTH GROUP | 21,510 | 0,00 % | Privia Health Group, Inc.: Privia Health Enters New Jersey | ||
| BRIGHTSPRING HEALTH SERVICES | 61,68 | -0,01 % | BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable | ||
| ALIGNMENT HEALTHCARE | 15,315 | -0,03 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| GERRESHEIMER | 27,200 | -2,51 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
27.05.2026 / 18:42 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,880 | -2,19 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| PROGYNY | 25,545 | -0,06 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| BILLIONTOONE | 98,87 | -0,12 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,710 | +0,32 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint | Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including... ► Artikel lesen | |
| HEARTFLOW | 31,000 | +0,06 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 16,520 | +1,98 % | Eckert & Ziegler sichert sich Blei-212-Versorgung von Thor Medical | Die Eckert & Ziegler SE hat mit dem norwegischen Isotopen-Spezialisten Thor Medical eine Kooperations- und Liefervereinbarung für das Radioisotop Blei-212 abgeschlossen. Thor Medical wird zunächst Blei-212... ► Artikel lesen |